Earnings Call · Q1 FY2022·2022-05-04

Q1 22EPS +2.22%·Rev n/aQ4 21EPS +4.44%·Rev n/aQ3 21EPS +6.98%·Rev n/aQ2 21EPS +14.63%·Rev n/a⚠ consensus missing

Adaptive Biotechnologies Corp ADPT

Disclaimer*

Karina Calzadilla — Investor Relations or Communications

Chad Robins — CEO

Kyle Piskel — CFO

+3.4%1d on move date+0.3% vs SPY3d−8.2%5d−19.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADPT calls or request research access.

More ADPT calls Browse calls Request research access